This inventor holds 1 USPTO granted patent. Top assignee: Novimmune Sa. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Walter Ferlin: Innovator in Bispecific Antibodies
Introduction
Walter Ferlin is a notable inventor based in Collonges-Sous-Salève, Australia. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. His work is crucial in advancing therapeutic methods for various diseases.
Latest Patents
Walter Ferlin holds a patent for "Bispecific Antibodies Targeting CD47 and PD-L1 and Methods of Use Thereof." This innovative patent addresses important mechanisms in cancer therapy, showcasing his expertise in antibody engineering. He has 1 patent to his name, reflecting his commitment to advancing medical science.
Career Highlights
Ferlin is currently associated with Novimmune SA, a company known for its focus on developing innovative antibody-based therapies. His role at Novimmune SA allows him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Walter Ferlin has worked alongside talented colleagues such as Xavier Chauchet and Krzysztof Masternak. Their combined efforts in research and development have led to significant advancements in the field of immunotherapy.
Conclusion
Walter Ferlin's contributions to the field of bispecific antibodies exemplify his dedication to innovation in biotechnology. His work continues to influence the development of new therapeutic strategies, making a lasting impact on medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile